Form 4 Tracker
IONIS PHARMACEUTICALS INC
IONS

78 insider filings · Latest: Jul 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 1, 2025Oct 1 8:39 PMSwayze Eric
Proposed Sale
27,114$66.00$1.8M

View →

Sep 30, 2025Sep 30 8:49 PMGeary Richard S
Proposed Sale
57,900$65.24$3.8M

View →

Sep 30, 2025Sep 30 8:39 PMHOUGEN ELIZABETH L
Proposed Sale
49,800$65.26$3.2M

View →

Sep 3, 2025Sep 3 9:31 PMLOSCALZO JOSEPH
Proposed Sale
16,000$60.15$962.4K

View →

Sep 3, 2025Sep 3 9:15 PMO'NEIL PATRICK R.
Proposed Sale
124,850$61.15$7.6M

View →

Sep 3, 2025Sep 3 8:54 PMBENNETT C FRANK
Proposed Sale
51,800$60.86$3.2M

View →

Sep 3, 2025Sep 3 8:37 PMBaroldi Joseph
Proposed Sale
45,000$59.09$2.7M

View →

Sep 3, 2025Sep 3 8:30 PMMonia Brett P
Proposed Sale
203,814$60.01$12.2M

View →

Sep 3, 2025Sep 3 8:21 PMDevers Shannon L.
Proposed Sale
3,162$61.02$193.0K

View →

Sep 3, 2025Sep 3 8:20 PMSchneider Eugene
Proposed Sale
19,658$60.81$1.2M

View →

Sep 3, 2024Sep 3 8:02 PMKLEIN JOSEPH III
Proposed Sale
28,000$60.00$1.7M

View →

Sep 2, 2025Sep 3 12:31 AMJoseph Wender
Proposed Sale
33,600$57.49$1.9M

View →

Sep 2, 2025Sep 2 9:34 PMSwayze Eric
Proposed Sale
11,130$49.67$552.9K

View →

Sep 2, 2025Sep 2 8:42 PMGeary Richard S
Proposed Sale
10,000$50.37$503.7K

View →

Sep 2, 2025Sep 2 8:34 PMO'NEIL PATRICK R.
Proposed Sale
13,050$54.51$711.4K

View →

Sep 2, 2025Sep 2 8:13 PMPARSHALL B LYNNE
Proposed Sale
20,000$50.91$1.0M

View →

Aug 22, 2025Aug 29 5:03 PMDiaz Allene M.
Proposed Sale
1,427$42.53$60.7K

View →

Aug 18, 2025Aug 18 8:26 PMBENNETT C FRANK
Proposed Sale
16,000$43.98$703.6K

View →

Aug 6, 2025Aug 6 8:10 PMPARSHALL B LYNNE
Proposed Sale
10,000$41.93$419.3K

View →

Aug 5, 2025Aug 5 8:17 PMGeary Richard S
Proposed Sale
10,000$42.86$428.6K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 3, 2026Mar 5 11:14 PMShannon L. DeversEVP, Chief Human Resources Ofc
Option Exercise
20,106$52.878,877(D)

View →

Mar 3, 2026Mar 5 11:13 PMBENNETT C FRANKEVP, Chief Scientific Officer
Option Exercise
65,089$60.890(D)

View →

Mar 4, 2026Mar 5 11:13 PMJoseph BaroldiEVP, Chief Business Officer
Option Exercise
439$56.783,866(I)

View →

Mar 3, 2026Mar 5 11:13 PMJoseph BaroldiEVP, Chief Business Officer
Option Exercise
1,699$56.784,104(I)

View →

Feb 2, 2026Feb 4 9:06 PMBENNETT C FRANKEVP, Chief Scientific Officer
Option Exercise
65,089$60.890(D)

View →

Jan 15, 2026Jan 21 1:21 AMMichael J. YangDirector
Option Exercise
1,9307,150(D)

View →

Jan 15, 2026Jan 21 1:21 AMEric SwayzeEVP Research
Option Exercise
21,477386(I)

View →

Jan 15, 2026Jan 21 1:21 AMEric SwayzeEVP Research
Grant/Award
35,700$0.00611(I)

View →

Jan 15, 2026Jan 21 1:21 AMEugene SchneiderEVP, Chf Clinical Develop Ofcr
Option Exercise
21,68539,251(D)

View →

Jan 15, 2026Jan 21 1:21 AMEugene SchneiderEVP, Chf Clinical Develop Ofcr
Grant/Award
35,475$0.0048,926(D)

View →

Jan 15, 2026Jan 21 1:20 AMPatrick R. O'NeilEVP CLO & General Counsel
Option Exercise
21,47339,251(D)

View →

Jan 15, 2026Jan 21 1:20 AMPatrick R. O'NeilEVP CLO & General Counsel
Grant/Award
35,475$0.0048,926(D)

View →

Jan 15, 2026Jan 21 1:20 AMBrett P MoniaDirector, Chief Executive Officer
Grant/Award
156,585$0.00205,719(D)

View →

Jan 15, 2026Jan 21 1:20 AMBrett P MoniaDirector, Chief Executive Officer
Option Exercise
89,145163,014(D)

View →

Jan 2, 2026Jan 21 1:20 AMHolly B. KordasiewiczEVP, Chief Development Officer
Grant/Award
7,500$79.6716,600(D)

View →

Jan 15, 2026Jan 21 1:18 AMHolly B. KordasiewiczEVP, Chief Development Officer
Option Exercise
11,11920,830(D)

View →

Jan 15, 2026Jan 21 1:18 AMHolly B. KordasiewiczEVP, Chief Development Officer
Grant/Award
24,90045,730(D)

View →

Jan 15, 2026Jan 21 1:18 AMKyle JenneEVP, Chf GL Pdt Str Ofcr
Option Exercise
7,01329,664(D)

View →

Jan 15, 2026Jan 21 1:18 AMKyle JenneEVP, Chf GL Pdt Str Ofcr
Grant/Award
35,475$0.0037,725(D)

View →

Jan 15, 2026Jan 21 1:18 AMHOUGEN ELIZABETH LEVP, Finance & CFO
Option Exercise
28,72955,940(D)

View →